![Frontiers | From Iron Chelation to Overload as a Therapeutic Strategy to Induce Ferroptosis in Leukemic Cells Frontiers | From Iron Chelation to Overload as a Therapeutic Strategy to Induce Ferroptosis in Leukemic Cells](https://www.frontiersin.org/files/MyHome%20Article%20Library/586530/586530_Thumb_400.jpg)
Frontiers | From Iron Chelation to Overload as a Therapeutic Strategy to Induce Ferroptosis in Leukemic Cells
![IJMS | Free Full-Text | The Iron Chelator Desferrioxamine Increases the Efficacy of Bedaquiline in Primary Human Macrophages Infected with BCG IJMS | Free Full-Text | The Iron Chelator Desferrioxamine Increases the Efficacy of Bedaquiline in Primary Human Macrophages Infected with BCG](https://pub.mdpi-res.com/ijms/ijms-22-02938/article_deploy/html/images/ijms-22-02938-ag.png?1616547051)
IJMS | Free Full-Text | The Iron Chelator Desferrioxamine Increases the Efficacy of Bedaquiline in Primary Human Macrophages Infected with BCG
Removal of Fe3+ and Zn2+ from plasma metalloproteins by iron chelating therapeutics depicted with SEC-ICP-AES - Dalton Transactions (RSC Publishing)
![An iron chelation-based combinatorial anticancer therapy comprising deferoxamine and a lactate excretion inhibitor inhibits the proliferation of cancer cells | Cancer & Metabolism | Full Text An iron chelation-based combinatorial anticancer therapy comprising deferoxamine and a lactate excretion inhibitor inhibits the proliferation of cancer cells | Cancer & Metabolism | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40170-022-00284-x/MediaObjects/40170_2022_284_Fig6_HTML.png)
An iron chelation-based combinatorial anticancer therapy comprising deferoxamine and a lactate excretion inhibitor inhibits the proliferation of cancer cells | Cancer & Metabolism | Full Text
![IJMS | Free Full-Text | Recent Advances in Iron Chelation and Gallium-Based Therapies for Antibiotic Resistant Bacterial Infections IJMS | Free Full-Text | Recent Advances in Iron Chelation and Gallium-Based Therapies for Antibiotic Resistant Bacterial Infections](https://www.mdpi.com/ijms/ijms-22-02876/article_deploy/html/images/ijms-22-02876-g001.png)
IJMS | Free Full-Text | Recent Advances in Iron Chelation and Gallium-Based Therapies for Antibiotic Resistant Bacterial Infections
![The Evolution of Iron Chelators for the Treatment of Iron Overload Disease and Cancer | Pharmacological Reviews The Evolution of Iron Chelators for the Treatment of Iron Overload Disease and Cancer | Pharmacological Reviews](https://pharmrev.aspetjournals.org/content/pharmrev/57/4/547/F2.large.jpg)
The Evolution of Iron Chelators for the Treatment of Iron Overload Disease and Cancer | Pharmacological Reviews
![Frontiers | Novel iron chelator SK4 demonstrates cytotoxicity in a range of tumour derived cell lines Frontiers | Novel iron chelator SK4 demonstrates cytotoxicity in a range of tumour derived cell lines](https://www.frontiersin.org/files/Articles/1005092/fmolb-09-1005092-HTML/image_m/fmolb-09-1005092-g001.jpg)
Frontiers | Novel iron chelator SK4 demonstrates cytotoxicity in a range of tumour derived cell lines
![Iron chelation cancer therapy using hydrophilic block copolymers conjugated with deferoxamine - Komoto - 2021 - Cancer Science - Wiley Online Library Iron chelation cancer therapy using hydrophilic block copolymers conjugated with deferoxamine - Komoto - 2021 - Cancer Science - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/e3289630-30ad-40d8-9a1f-1658ce2099c5/cas14607-fig-0001-m.jpg)
Iron chelation cancer therapy using hydrophilic block copolymers conjugated with deferoxamine - Komoto - 2021 - Cancer Science - Wiley Online Library
![Pharmaceuticals | Free Full-Text | The Efficacy of Iron Chelators for Removing Iron from Specific Brain Regions and the Pituitary—Ironing out the Brain Pharmaceuticals | Free Full-Text | The Efficacy of Iron Chelators for Removing Iron from Specific Brain Regions and the Pituitary—Ironing out the Brain](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-12-00138/article_deploy/html/images/pharmaceuticals-12-00138-g001.png)
Pharmaceuticals | Free Full-Text | The Efficacy of Iron Chelators for Removing Iron from Specific Brain Regions and the Pituitary—Ironing out the Brain
The Clinically Used Iron Chelator Deferasirox Is an Inhibitor of Epigenetic JumonjiC Domain-Containing Histone Demethylases | ACS Chemical Biology
![Synthetic and natural iron chelators: therapeutic potential and clinical use | Future Medicinal Chemistry Synthetic and natural iron chelators: therapeutic potential and clinical use | Future Medicinal Chemistry](https://www.future-science.com/cms/10.4155/fmc.09.121/asset/images/medium/graphic85.gif)
Synthetic and natural iron chelators: therapeutic potential and clinical use | Future Medicinal Chemistry
![Natural Iron Chelators as Potential Therapeutic Agents for the Treatment of Iron Overload Diseases | IntechOpen Natural Iron Chelators as Potential Therapeutic Agents for the Treatment of Iron Overload Diseases | IntechOpen](https://cdnintech.com/media/chapter/77500/1512345123/media/F1.png)